Thevananthan相关文献与解析，生知库 | 链接生命科学的每一步

Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months

评估灭活新冠疫苗在接种后 3 个月时的异源和同源加强免疫效果，并与 BNT162b2 疫苗在接种后 6 个月时的同源加强免疫效果进行比较

doi:10.1001/jamanetworkopen.2022.26046

Low, Ee Vien; Tok, Peter Seah Keng; Husin, Masliyana; Suah, Jing Lian; Tng, Boon Hwa; Thevananthan, Thevesh; Appannan, Maheshwara Rao; Yahaya, Hazlina; Mohd Zin, Shahanizan; Muhamad Zin, Faizah; Sivasampu, Sheamini; Peariasamy, Kalaiarasu M

Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection

同源和异源BNT162b2、CoronaVac和AZD1222加强疫苗对Delta和Omicron SARS-CoV-2感染的实际有效性

期刊:Emerging Microbes & Infections

影响因子:7.5

doi:10.1080/22221751.2022.2072773

Suah, Jing Lian; Tng, Boon Hwa; Tok, Peter Seah Keng; Husin, Masliyana; Thevananthan, Thevesh; Peariasamy, Kalaiarasu M; Sivasampu, Sheamini

Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study

马来西亚BNT162b2和CoronaVac新冠疫苗效力减弱：一项观察性研究

期刊:International Journal of Infectious Diseases

影响因子:4.3

doi:10.1016/j.ijid.2022.03.028

Suah, Jing Lian; Husin, Masliyana; Tok, Peter Seah Keng; Tng, Boon Hwa; Thevananthan, Thevesh; Low, Ee Vien; Appannan, Maheshwara Rao; Muhamad Zin, Faizah; Mohd Zin, Shahanizan; Yahaya, Hazlina; Peariasamy, Kalaiarasu M; Sivasampu, Sheamini

PICK-ing Malaysia's Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio

深入剖析马来西亚疫情：多种新冠疫苗组合的有效性

期刊:Vaccines

影响因子:3.4

doi:10.3390/vaccines9121381

Suah, Jing Lian; Tok, Peter Seah Keng; Ong, Su Miin; Husin, Masliyana; Tng, Boon Hwa; Sivasampu, Sheamini; Thevananthan, Thevesh; Appannan, Maheshwara Rao; Muhamad Zin, Faizah; Mohd Zin, Shahanizan; Yahaya, Hazlina; Rusli, Norhayati; Ujang, Mohd Fikri; Mohd Ibrahim, Hishamshah; Abdullah, Noor Hisham; Peariasamy, Kalaiarasu M

The Malaysian Election Corpus (MECo): Federal and State-Level Election Results from 1955 to 2025

马来西亚选举资料库（MECo）：1955年至2025年联邦和州级选举结果

Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months

评估灭活新冠疫苗在接种后 3 个月时的异源和同源加强免疫效果，并与 BNT162b2 疫苗在接种后 6 个月时的同源加强免疫效果进行比较

Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection

同源和异源BNT162b2、CoronaVac和AZD1222加强疫苗对Delta和Omicron SARS-CoV-2感染的实际有效性

Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study

马来西亚BNT162b2和CoronaVac新冠疫苗效力减弱：一项观察性研究

PICK-ing Malaysia's Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio

深入剖析马来西亚疫情：多种新冠疫苗组合的有效性